Xiang Yang Yang

Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China.

Shenzhen Zhongmai Digital Medical Technology Co., Ltd. provides medical solution and information. The company was founded by Zi Niu Lin in January 2009 and is headquartered in Shenzhen, China.

Beijing SBI & TH Venture Capital Co. Ltd. (SBI & TH) is a venture capital investment firm located in Beijing, China. The firm was founded in 2007 as a joint venture by Tsinghua Holdings, a wholly-owned subsidiary of Tsinghua University in Beijing, a leading science, technology and engineering educational institution in China, and SBI Holdings (TSE: 8473), formerly known as Softbank Investment Corporation, a large venture capital group in Japan. SBI & TH specializes in venture capital investment, consulting, and related project management. They are the investment managers of SBI & TH Venture Capital Fund.